The 2025 CHALLENGE study led by the Canadian Cancer Trials Group followed 889 people with stage 2 or 3 colon cancer in six countries, mostly Canada and Australia, who had finished surgery and chemotherapy after enrollment from 2009; one arm received only health education while the other added three